Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19451849rdf:typepubmed:Citationlld:pubmed
pubmed-article:19451849lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:19451849lifeskim:mentionsumls-concept:C1521725lld:lifeskim
pubmed-article:19451849lifeskim:mentionsumls-concept:C0015505lld:lifeskim
pubmed-article:19451849lifeskim:mentionsumls-concept:C0524727lld:lifeskim
pubmed-article:19451849pubmed:issue5lld:pubmed
pubmed-article:19451849pubmed:dateCreated2009-9-10lld:pubmed
pubmed-article:19451849pubmed:abstractTextPostoperative hemorrhage is a recognized complication of pediatric cardiac surgery. Both the immature coagulation system and increased susceptibility to hemodilution increase the likelihood of pediatric patients developing coagulopathy when compared with adult counterparts. Treatment options remain limited. Recombinant factor VII (rFVIIa) is a hemostatic agent increasingly used to reduce hemorrhage in other surgical settings, the role of which is unclear in this population. This article systematically reviews the published literature on the use of rFVIIa in pediatric cardiac surgery.lld:pubmed
pubmed-article:19451849pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19451849pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19451849pubmed:languageenglld:pubmed
pubmed-article:19451849pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19451849pubmed:citationSubsetIMlld:pubmed
pubmed-article:19451849pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19451849pubmed:statusMEDLINElld:pubmed
pubmed-article:19451849pubmed:monthSeplld:pubmed
pubmed-article:19451849pubmed:issn1529-7535lld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:GillRaviRlld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:AthanasiouTha...lld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:DarziAra WAWlld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:WarrenOliver...lld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:RogersPaula...lld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:WatretAmy LALlld:pubmed
pubmed-article:19451849pubmed:authorpubmed-author:de WitKatie...lld:pubmed
pubmed-article:19451849pubmed:issnTypePrintlld:pubmed
pubmed-article:19451849pubmed:volume10lld:pubmed
pubmed-article:19451849pubmed:ownerNLMlld:pubmed
pubmed-article:19451849pubmed:authorsCompleteYlld:pubmed
pubmed-article:19451849pubmed:pagination572-82lld:pubmed
pubmed-article:19451849pubmed:dateRevised2010-7-8lld:pubmed
pubmed-article:19451849pubmed:meshHeadingpubmed-meshheading:19451849...lld:pubmed
pubmed-article:19451849pubmed:meshHeadingpubmed-meshheading:19451849...lld:pubmed
pubmed-article:19451849pubmed:meshHeadingpubmed-meshheading:19451849...lld:pubmed
pubmed-article:19451849pubmed:meshHeadingpubmed-meshheading:19451849...lld:pubmed
pubmed-article:19451849pubmed:meshHeadingpubmed-meshheading:19451849...lld:pubmed
pubmed-article:19451849pubmed:year2009lld:pubmed
pubmed-article:19451849pubmed:articleTitleDefining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?lld:pubmed
pubmed-article:19451849pubmed:affiliationDepartment of BioSurgery and Surgical Technology, Imperial College London, St. Mary's Hospital, London, United Kingdom. o.warren@imperial.ac.uklld:pubmed
pubmed-article:19451849pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19451849pubmed:publicationTypeReviewlld:pubmed
pubmed-article:19451849pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19451849lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19451849lld:pubmed